Detalles de la búsqueda
1.
Clinical efficacy of PARP inhibitors in breast cancer.
Breast Cancer Res Treat
; 200(1): 15-22, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37129747
2.
Uveitis, a rare but important complication of adjuvant zoledronic acid for early-stage breast cancer.
Anticancer Drugs
; 34(4): 592-594, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36846985
3.
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.
N Engl J Med
; 380(25): 2395-2405, 2019 06 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31157962
4.
SARS-CoV-2 nosocomial infection: Real-world results of environmental surface testing from a large tertiary cancer center.
Cancer
; 127(11): 1926-1932, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33599303
5.
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.
N Engl J Med
; 379(2): 111-121, 2018 Jul 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29860917
6.
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.
N Engl J Med
; 373(21): 2005-14, 2015 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-26412349
7.
Adapting and implementing breast cancer follow-up in primary care: protocol for a mixed methods hybrid type 1 effectiveness-implementation cluster randomized study.
BMC Prim Care
; 24(1): 235, 2023 11 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37946132
8.
Improving Uptake of Cancer Genetic Risk Assessment in a Remote Tailored Risk Communication and Navigation Intervention: Large Effect Size but Room to Grow.
J Clin Oncol
; 41(15): 2767-2778, 2023 05 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36787512
9.
Association Between Biomarkers and Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Metastatic Triple-Negative Breast Cancer: KEYNOTE-086 Exploratory Analysis.
JCO Precis Oncol
; 7: e2200317, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37099733
10.
Polymorphic variants in TSC1 and TSC2 and their association with breast cancer phenotypes.
Breast Cancer Res Treat
; 125(3): 861-8, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20658316
11.
Clinical and Pharmacologic Differences of CDK4/6 Inhibitors in Breast Cancer.
Front Oncol
; 11: 693104, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34327137
12.
Durable Response to PD1 Inhibitor Pembrolizumab in a Metastatic, Metaplastic Breast Cancer.
Case Rep Oncol
; 14(2): 931-937, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34248561
13.
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial.
J Natl Cancer Inst
; 113(4): 390-399, 2021 04 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32986828
14.
Testing considerations for phosphatidylinositol-3-kinase catalytic subunit alpha as an emerging biomarker in advanced breast cancer.
Cancer Med
; 9(18): 6463-6472, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32697890
15.
Personalized Management of Chemotherapy-Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance).
J Clin Pharmacol
; 60(4): 444-452, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31802506
16.
TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial).
J Clin Oncol
; 38(14): 1539-1548, 2020 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32097092
17.
Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial.
JAMA Oncol
; 6(3): 367-374, 2020 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31566680
18.
A polymorphic variant in human MDM4 associates with accelerated age of onset of estrogen receptor negative breast cancer.
Carcinogenesis
; 30(11): 1910-5, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19762336
19.
Kinetic-Pharmacodynamic Model of Chemotherapy-Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel, or Ixabepilone: CALGB 40502 (Alliance).
AAPS J
; 19(5): 1411-1423, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28620884
20.
A phase I trial of a potent P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), administered orally in combination with doxorubicin in patients with advanced malignancies.
Clin Cancer Res
; 8(12): 3710-7, 2002 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-12473580